VoltarVoltarReceita antes de impostos de Spero Therapeutics, Inc..
Dados anuais
2016
2017
2018
2019
2020
2021
2022
2023
TTM
−90,00 M
−60,00 M
−30,00 M
0,00
30,00 M
Período
Valor
Variação
Variação %
TTM
3,61 M
−21,79 M
−85,79%
2023
25,40 M
+71,82 M
—
2022
−46,41 M
+43,34 M
+48,29%
2021
−89,76 M
−11,48 M
−14,66%
2020
−78,28 M
−17,36 M
−28,49%
2019
−60,92 M
−19,26 M
−46,24%
Dados trimestrais
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
−20,00 M
0,00
20,00 M
40,00 M
60,00 M
Período
Valor
Variação
Variação %
Q3 '24
−17,44 M
+425,00 K
+2,38%
Q2 '24
−17,86 M
−5,19 M
−40,99%
Q1 '24
−12,67 M
−64,25 M
−124,56%
Q4 '23
51,58 M
+52,57 M
—
Q3 '23
−994,00 K
+10,92 M
+91,66%
Q2 '23
−11,91 M
+1,35 M
+10,19%
Q1 '23
−13,27 M
−40,04 M
−149,55%
Q4 '22
26,77 M
+38,45 M
—